Results 21 to 30 of about 14,868 (228)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease

open access: yesEJNMMI Research, 2021
Background Using two static scans for 123I-meta-iodobenzyl-guanidine (123I-MIBG) myocardial scintigraphy ignores the dynamic response from vesicular trapping in nerve terminals. Moreover, the long pause between scans is impractical for patients with Lewy
Yoshitaka Kumakura   +9 more
doaj   +1 more source

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report

open access: yesBMC Research Notes, 2017
Background Pheochromocytomas are rare neuroendocrine tumors, with a malignancy frequency of approximately 10%. The treatment of malignant pheochromocytoma is palliative, and the traditional management strategy has limited efficacy.
Teruaki Sugino   +15 more
doaj   +1 more source

The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis

open access: yesBMC Cancer, 2022
Objective Neuroblastoma is a common extracranial solid tumor of childhood. Recently, multiple treatments have been practiced including Iodine-131-metaiodobenzylguanidine radiation (131I-MIBG) therapy.
Huihui He, Qiaoling Xu, Chunjing Yu
doaj   +1 more source

Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder

open access: yesJournal of Parkinson’s Disease, 2022
Background: Isolated rapid eye movement sleep behavior disorder (iRBD) is prodromal for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Objective: We investigated the use of cardiac [ 123 I]meta-iodo-benzyl-guanidine scintigraphy ([ 123 I ...
Annette Janzen   +11 more
doaj   +1 more source

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species [PDF]

open access: yes, 2013
Background The radiopharmaceutical 131I-metaiodobenzylguanidine (131I-MIBG) is used for the targeted radiotherapy of noradrenaline transporter (NAT)-expressing neuroblastoma.
Babich, J.W.   +4 more
core   +3 more sources

Adrenal pheochromocytoma incidentally discovered in a patient with parkinsonism [PDF]

open access: yes, 2015
To evaluate the diagnostic route of pheochromocytoma (PHEO) in a patient under dopaminergic treatment. A 70-year-old man with Parkinsonism and under treatment with levodopa and carbidopa came to our observation for evaluation of arterial hypertension and
Claudio Letizia   +7 more
core   +1 more source

Impact of mediastinal, liver and lung I-metaiodobenzylguanidine (I-MIBG) washout on calculated I-MIBG myocardial washout [PDF]

open access: yes, 2009
PURPOSE: In planar (123)I-metaiodobenzylguanidine ((123)I-MIBG) myocardial imaging mediastinum (M) activity is often used as a background correction in calculating "washout" (WO).
Hein J. Verberne   +4 more
core   +9 more sources

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review

open access: yesBrain Sciences, 2023
Cardiac sympathetic denervation, as documented on 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy, is relatively sensitive and specific for distinguishing Parkinson’s disease (PD) from other neurodegenerative causes of parkinsonism.
Jamir Pitton Rissardo   +1 more
doaj   +1 more source

Rapid iododeboronation with and without gold catalysis: application to radiolabelling of arenes [PDF]

open access: yes, 2017
Radiopharmaceuticals incorporating radioactive iodine in combination with SPECT imaging play a key role in nuclear medicine, with applications in drug development and disease diagnosis.
Fletcher, Conor   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy